Clinical Trial

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

Study acronym: ENDURANCE™
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
Protocol Amendment History 1 change
notable Trial sites expanded: 5 -> 8 locations 2026-06-27
Trial Details
NCT Number NCT07456865
Lead Sponsor MedtronicNeuro
Conditions Urge Urinary Incontinence
Enrollment 256 participants
Start Date 2026-03-17
Primary Completion 2032-11 (estimated)
Study Completion 2032-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-17